Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 200 Total
PGSS - Pegasus Digital Mobility Acquisition Corp - Stock Price Chart
TickerPGSS [NYSE]
CompanyPegasus Digital Mobility Acquisition Corp
CountryCayman Islands
IndustryShell Companies
Market Cap60.72MEPS (ttm)-0.12
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.71EPS Q/Q-100.11%
Dividend-Sales Q/Q-
Insider Own55.91%Inst Own43.28%
Insider Trans0.00%Inst Trans101.48%
Short Float1.28%Earnings-
Analyst Recom-Target Price-
Avg Volume69.70K52W Range9.85 - 11.50
Apr-11-24 03:18PM Pegasus Digital Mobility Acquisition Corp. Announces Entry into Several Non-Redemption and Investment Agreements and the Addition of Two Independent Board Members to the Schmid Group N.V. Board of Directors (Business Wire)
Feb-20-24 04:05PM Calumet Electronics And Schmid Group Collaborate To Establish First-Ever US Advanced Substrate Facility (Business Wire)
Jan-29-24 04:01PM Pegasus Digital Mobility Acquisition Corp. Announces Revaluation of its Business Combination with Gebr. Schmid Group and the Entering Into Related Agreements (Business Wire)
Jan-24-24 04:01PM Pegasus Digital Mobility Acquisition Corp. Receives Continued Listing Standard Notice from NYSE (Business Wire)
Dec-29-23 11:55AM Pegasus Digital Mobility Acquisition Corp. Announces the Extension of the Combination Period until April 30, 2024 (Business Wire)
Dec-07-23 04:31PM Pegasus Digital Mobility Acquisition Corp. Announces the Results of its Extraordinary General Meeting and Amendment of its Memorandum and Articles of Association (Business Wire)
Jul-27-23 09:37AM Pegasus Digital Mobility Acquisition Corp. Announces Redemption Results and Confirms Voluntary Payment Amount (Business Wire)
Jul-14-23 04:15PM Pegasus Digital Mobility Acquisition Corp. Announces Third Extension and Further Voluntary Payments Into Trust Account (Business Wire)
May-31-23 08:00AM The SCHMID GROUP to List on NYSE through Business Combination with Pegasus Digital Mobility Acquisition Corp. (PR Newswire)
Apr-24-23 04:01PM Pegasus Digital Mobility Acquisition Corp. Announces the Second Three-Months Extension of the Combination Period (Business Wire)
Pegasus Digital Mobility Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on March 30, 2021 and is headquartered in George Town, Cayman Islands.
CETX - Cemtrex Inc. - Stock Price Chart
TickerCETX [NASD]
CompanyCemtrex Inc.
CountryUSA
IndustrySoftware - Infrastructure
Market Cap1.21MEPS (ttm)-4.29
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y50.20%
P/S0.02EPS next 5Y-
P/B0.18EPS Q/Q77.03%
Dividend-Sales Q/Q41.00%
Insider Own6.40%Inst Own1.96%
Insider Trans0.00%Inst Trans-89.46%
Short Float1.41%EarningsFeb 12/a
Analyst Recom1.00Target Price11.00
Avg Volume61.47K52W Range1.61 - 11.45
Cemtrex, Inc. engages in the provision of solutions in the technology industry. It operates through the following segments: Security, Industrial Services, and Cemtrex Corporate. The Security segment provides end-to-end security solutions to meet corporate, industrial, and governmental security challenges. The Industrial Services segment offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. The Cemtrex Corporate segment refers to the holding company of the other two segments. The company was founded on April 27, 1998 and is headquartered in Hauppauge, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GOVIL SAAGARCEOAug 30 '23Buy0.9515,10014,380132,298Sep 05 04:30 PM
GOVIL SAAGARCFOAug 25 '23Buy0.917,1006,461116,486Aug 29 04:15 PM
GOVIL SAAGARCFOAug 24 '23Buy0.933,0002,789109,386Aug 29 04:15 PM
GOVIL SAAGARCFOJun 15 '23Buy0.9727,79826,836106,386Jun 21 08:23 AM
GOVIL SAAGARCEOJun 14 '23Buy0.938,0287,48578,588Jun 14 04:56 PM
BKKT - Bakkt Holdings Inc - Stock Price Chart
TickerBKKT [NYSE, RUT]
CompanyBakkt Holdings Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap39.05MEPS (ttm)-16.48
P/E-EPS this Y66.67%
Forward P/E-EPS next Y30.95%
PEG-EPS past 5Y-
P/S0.05EPS next 5Y-
P/B0.53EPS Q/Q76.12%
Dividend-Sales Q/Q1275.09%
Insider Own-Inst Own-
Insider Trans-Inst Trans1.70%
Short Float-EarningsMar 25/a
Analyst Recom2.00Target Price31.25
Avg Volume247.08K52W Range8.27 - 68.75
Bakkt Holdings, Inc. engages in the intersection of cryptoassets, loyalty and rewards, and payments. It also provides a platform to expand payment offerings, create new revenue streams, and increase customer loyalty. The company was founded in 2018 and is headquartered in Alpharetta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Intercontinental Exchange, Inc10% OwnerApr 25 '24Buy0.87350,880304,213649,934Apr 29 09:11 PM
Intercontinental Exchange, Inc10% OwnerMar 04 '24Buy0.872,762,0092,394,6627,476,345Mar 04 05:34 PM
D'Annunzio MarcGeneral Counsel & SecretaryFeb 23 '24Sale0.8850,24744,047566,630Feb 26 09:28 PM
D'Annunzio MarcGeneral Counsel & SecretaryFeb 08 '24Sale0.9819,32918,927638,157Feb 09 09:13 PM
D'Annunzio MarcGeneral Counsel & SecretaryJan 25 '24Sale1.2742,80754,249667,320Jan 29 07:19 PM
LICN - Lichen China Ltd - Stock Price Chart
TickerLICN [NASD]
CompanyLichen China Ltd
CountryChina
IndustrySpecialty Business Services
Market Cap37.26MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-78.21%
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own51.56%Inst Own0.00%
Insider Trans0.00%Inst Trans-
Short Float0.49%Earnings-
Analyst Recom-Target Price-
Avg Volume935.32K52W Range0.50 - 3.22
Lichen China Ltd. engages in providing financial and taxation solutions. It also offers educational support, and software and maintenance services. The company was founded by Li Ya on April 13, 2016 and is headquartered in Jinjiang, China.
CHGG - Chegg Inc - Stock Price Chart
TickerCHGG [NYSE, RUT]
CompanyChegg Inc
CountryUSA
IndustryEducation & Training Services
Market Cap532.25MEPS (ttm)-0.40
P/E-EPS this Y-4.10%
Forward P/E4.68EPS next Y4.61%
PEG-EPS past 5Y-20.81%
P/S0.76EPS next 5Y20.00%
P/B0.55EPS Q/Q-178.98%
Dividend-Sales Q/Q-7.06%
Insider Own4.06%Inst Own97.64%
Insider Trans-0.45%Inst Trans-4.01%
Short Float14.26%EarningsApr 29/a
Analyst Recom3.67Target Price7.40
Avg Volume2.68M52W Range6.63 - 17.92
Apr-30-24Downgrade Jefferies Hold → Underperform $7 → $4
Apr-30-24Downgrade Craig Hallum Buy → Hold $13 → $7
Chegg, Inc. engages in providing support and a learning platform for students. Its services include Chegg Study Pack, Chegg Study, Chegg Writing, Chegg Math, Busuu offerings, Chegg Skills, advertising services, print textbooks, and eTextbooks offerings. The company was founded by Osman Rashid and Aayush Phumbhra on July 29, 2005 and is headquartered in Santa Clara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schultz Nathan J.CHIEF OPERATING OFFICERDec 13 '23Sale10.411,35014,054421,025Dec 14 05:11 PM
Schultz Nathan J.CHIEF OPERATING OFFICERDec 04 '23Sale10.136306,382426,802Dec 05 01:35 PM
BROWN ANDREW JCHIEF FINANCIAL OFFICERNov 27 '23Sale10.0216,921169,54891,922Nov 29 07:52 PM
Schultz Nathan J.CHIEF OPERATING OFFICERSep 13 '23Sale10.061,54715,563429,501Sep 14 07:27 PM
Schultz Nathan J.CHIEF OPERATING OFFICERSep 05 '23Sale10.608188,672434,816Sep 06 04:38 PM
NRXP - NRX Pharmaceuticals Inc - Stock Price Chart
TickerNRXP [NASD]
CompanyNRX Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap24.69MEPS (ttm)-1.54
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-235.69%
Dividend-Sales Q/Q-
Insider Own20.20%Inst Own4.20%
Insider Trans0.00%Inst Trans-
Short Float6.69%EarningsMar 28/b
Analyst Recom1.00Target Price20.00
Avg Volume219.85K52W Range2.21 - 12.00
Apr-30-24 08:30AM NRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar Depression (PR Newswire) -27.32%
Apr-18-24 08:56AM Why Is NRX Pharmaceuticals (NRXP) Stock Down 29% Today? (InvestorPlace) -27.75%
08:32AM NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement (PR Newswire)
08:30AM NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock (PR Newswire)
Apr-17-24 04:45PM NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock (PR Newswire)
08:30AM NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics: Potential Implications for Avoidance of C. Difficile infections (PR Newswire)
Apr-15-24 08:30AM NRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine) (PR Newswire)
Apr-08-24 08:30AM NRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression (PR Newswire)
Apr-04-24 12:00PM NRx Pharmaceuticals (NRXP) Upgraded to Strong Buy: Here's What You Should Know (Zacks) +9.70%
Apr-02-24 10:33AM NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q4 2023 Earnings Call Transcript (Insider Monkey)
NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hurvitz ChaimDirectorAug 30 '23Buy0.2970,00020,125570,000Sep 11 09:15 AM
Gorovitz AaronDirectorAug 30 '23Buy0.3235,00011,196105,000Sep 11 09:19 AM
Javitt Jonathan CChief ScientistAug 23 '23Buy0.33100,00033,000446,332Aug 24 12:14 PM
Javitt Jonathan CChief ScientistAug 22 '23Buy0.32200,00064,400346,332Aug 23 09:24 AM
HWH - HWH International Inc. - Stock Price Chart
TickerHWH [NASD]
CompanyHWH International Inc.
CountryUSA
IndustryLeisure
Market Cap31.14MEPS (ttm)0.06
P/E30.00EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.48EPS Q/Q-453.70%
Dividend-Sales Q/Q-
Insider Own86.76%Inst Own9.29%
Insider Trans0.00%Inst Trans5.28%
Short Float5.37%Earnings-
Analyst Recom-Target Price-
Avg Volume1.42M52W Range0.75 - 15.04
HWH International, Inc. operates as a lifestyle business through a membership model. It enables home-based people in the new GIG economy to create lasting wealth. Its segments include HWH Marketplace, Hapi Cafe, Hapi Travel Destinations, and Hapi Wealth Builder. HWH Marketplace offers discounted sale of certain products, manufactured by affiliate company, Sharing Services Global Corp., to members. Hapi Cafe offers location-based social experiences where members can build a sense of community with like-minded customers with a potential interest in the same products. Hapi Travel Destinations aims to offer exclusive access to unpublished rates and discounts on air travel, cruises, car rentals, hotels, and resorts for members. Hapi Wealth Builder is exploring options of providing services to members through educational materials and seminars aimed at various types of investing opportunities. The company is headquartered in Bethesda, MD.
ANVS - Annovis Bio Inc - Stock Price Chart
TickerANVS [NYSE]
CompanyAnnovis Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap61.33MEPS (ttm)-6.22
P/E-EPS this Y55.84%
Forward P/E-EPS next Y9.33%
PEG-EPS past 5Y-126.41%
P/S-EPS next 5Y-
P/B-EPS Q/Q-515.14%
Dividend-Sales Q/Q-
Insider Own26.05%Inst Own11.40%
Insider Trans0.00%Inst Trans-3.09%
Short Float17.85%EarningsApr 04/a
Analyst Recom1.80Target Price33.40
Avg Volume387.25K52W Range5.23 - 22.49
Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs which aim to treat neurodegenerative diseases such as Alzheimer's (AD) and Parkinson's (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Its product pipeline also includes ANVS405 and ANVS301, which focus on the treatment of traumatic brain injury, stroke, and advanced AD. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Malvern, PA.
MED - Medifast Inc - Stock Price Chart
TickerMED [NYSE, RUT]
CompanyMedifast Inc
CountryUSA
IndustryPersonal Services
Market Cap300.08MEPS (ttm)6.20
P/E4.44EPS this Y-92.06%
Forward P/E14.57EPS next Y147.06%
PEG0.22EPS past 5Y14.53%
P/S0.33EPS next 5Y20.00%
P/B1.43EPS Q/Q-79.31%
Dividend11.99%Sales Q/Q-49.93%
Insider Own2.67%Inst Own95.40%
Insider Trans-1.27%Inst Trans-1.84%
Short Float28.20%EarningsApr 29/a
Analyst Recom3.00Target Price37.50
Avg Volume391.96K52W Range30.95 - 109.52
Medifast, Inc. engages in the provision of healthy living products and programs. It offers the OPTAVIA brand, a lifestyle solution centered on developing new healthy habits through smaller, foundational changes called micro-habits. The firm's product line includes bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The company was founded by William Vitale in 1981 and is headquartered in Baltimore, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SCHLACKMAN SCOTTDirectorMar 08 '24Option Exercise27.681,30035,98411,838Mar 12 05:18 PM
SCHLACKMAN SCOTTDirectorMar 08 '24Sale39.444,053159,8667,785Mar 12 05:18 PM
BROWN JEFFREY JDirectorNov 07 '23Buy68.89584,0205,784Nov 09 08:19 PM
SCHLACKMAN SCOTTDirectorNov 07 '23Buy68.89533,62710,538Nov 09 08:19 PM
Thomas Andrea BDirectorNov 07 '23Buy68.89503,4716,253Nov 09 08:20 PM
BRNS - Barinthus Biotherapeutics Plc. ADR - Stock Price Chart
TickerBRNS [NASD]
CompanyBarinthus Biotherapeutics Plc. ADR
CountryUnited Kingdom
IndustryBiotechnology
Market Cap79.21MEPS (ttm)-1.92
P/E-EPS this Y-21.69%
Forward P/E-EPS next Y-1.12%
PEG-EPS past 5Y-
P/S97.79EPS next 5Y-
P/B0.42EPS Q/Q20.23%
Dividend-Sales Q/Q-100.00%
Insider Own7.61%Inst Own17.56%
Insider Trans0.00%Inst Trans57.00%
Short Float0.04%EarningsMar 20/b
Analyst Recom1.50Target Price7.40
Avg Volume22.21K52W Range1.64 - 5.10
Barinthus Biotherapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. It also focuses on the pipeline of both clinical and preclinical stage therapeutic, and prophylactic programs. The company was founded by Adrian Hill and Dame Sarah Gilbert in March 2021 and is headquartered in Didcot, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Scheeren JosephDirectorJun 26 '23Buy2.4410,00024,40023,000Jun 28 07:52 AM
Wright RobinDirectorMay 25 '23Buy2.6613,75036,61248,256Jun 01 04:33 PM
1234561020